Skip to content
Home/Companies/Biotech/Buzzard Pharmaceuticals

Buzzard Pharmaceuticals

Biotech·Sweden·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Buzzard Pharmaceuticals?

Buzzard Pharmaceuticals is currently owned by Flerie through Flerie Invest (2011 vintage), since 2021.

Hand-verified · updated 2026-08-17

Flerie
Investor
Flerie
Flerie Invest · 2011 · Life Sciences VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from Flerie Invest

Other portfolio companies in the same fund.

Frontier Biosolutions
Active
PharmaGermany· 2023
Mendus
Active
BiotechSweden· 2023
A3P Biomedical
Exited 2025
BiotechSweden· 2022
Alder Therapeutics
Active
BiotechSweden· 2022
AnaCardio
Active
BiotechSweden· 2022
Bohus Biotech
Active
PharmaSweden· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Buzzard Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Buzzard Pharmaceuticals?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Buzzard Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue